chr19-7745597-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_021155.4(CD209):c.669G>A(p.Lys223Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000524 in 634,964 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00025 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00061 ( 3 hom. )
Consequence
CD209
NM_021155.4 synonymous
NM_021155.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.854
Publications
4 publications found
Genes affected
CD209 (HGNC:1641): (CD209 molecule) This gene encodes a C-type lectin that functions in cell adhesion and pathogen recognition. This receptor recognizes a wide range of evolutionarily divergent pathogens with a large impact on public health, including leprosy and tuberculosis mycobacteria, the Ebola, hepatitis C, HIV-1 and Dengue viruses, and the SARS-CoV acute respiratory syndrome coronavirus. The protein is organized into four distinct domains: a C-terminal carbohydrate recognition domain, a flexible tandem-repeat neck domain, a transmembrane region and an N-terminal cytoplasmic domain involved in internalization. This gene is closely related in terms of both sequence and function to a neighboring gene, CLEC4M (Gene ID: 10332), also known as L-SIGN. The two genes differ in viral recognition and expression patterns, with this gene showing high expression on the surface of dendritic cells. Polymorphisms in the neck region are associated with protection from HIV-1 infection, while single nucleotide polymorphisms in the promoter of this gene are associated with differing resistance and susceptibility to and severity of infectious disease, including rs4804803, which is associated with SARS severity. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 19-7745597-C-T is Benign according to our data. Variant chr19-7745597-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2649174.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.854 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CD209 | ENST00000315599.12 | c.669G>A | p.Lys223Lys | synonymous_variant | Exon 4 of 7 | 1 | NM_021155.4 | ENSP00000315477.6 | ||
| ENSG00000288669 | ENST00000678003.1 | n.66G>A | non_coding_transcript_exon_variant | Exon 1 of 13 | ENSP00000504497.1 |
Frequencies
GnomAD3 genomes AF: 0.000246 AC: 37AN: 150592Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
37
AN:
150592
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000189 AC: 40AN: 211406 AF XY: 0.000198 show subpopulations
GnomAD2 exomes
AF:
AC:
40
AN:
211406
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000611 AC: 296AN: 484258Hom.: 3 Cov.: 0 AF XY: 0.000857 AC XY: 223AN XY: 260186 show subpopulations
GnomAD4 exome
AF:
AC:
296
AN:
484258
Hom.:
Cov.:
0
AF XY:
AC XY:
223
AN XY:
260186
show subpopulations
African (AFR)
AF:
AC:
1
AN:
12782
American (AMR)
AF:
AC:
0
AN:
19504
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
13918
East Asian (EAS)
AF:
AC:
0
AN:
32010
South Asian (SAS)
AF:
AC:
268
AN:
47062
European-Finnish (FIN)
AF:
AC:
0
AN:
39084
Middle Eastern (MID)
AF:
AC:
4
AN:
2068
European-Non Finnish (NFE)
AF:
AC:
17
AN:
290476
Other (OTH)
AF:
AC:
6
AN:
27354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000246 AC: 37AN: 150706Hom.: 0 Cov.: 31 AF XY: 0.000353 AC XY: 26AN XY: 73658 show subpopulations
GnomAD4 genome
AF:
AC:
37
AN:
150706
Hom.:
Cov.:
31
AF XY:
AC XY:
26
AN XY:
73658
show subpopulations
African (AFR)
AF:
AC:
1
AN:
40980
American (AMR)
AF:
AC:
0
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3450
East Asian (EAS)
AF:
AC:
0
AN:
5080
South Asian (SAS)
AF:
AC:
29
AN:
4700
European-Finnish (FIN)
AF:
AC:
0
AN:
10490
Middle Eastern (MID)
AF:
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
AC:
6
AN:
67516
Other (OTH)
AF:
AC:
1
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jan 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CD209: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.